219 related articles for article (PubMed ID: 6609268)
1. Symptoms and activation of granulocytes and complement with two dialysis membranes.
Ivanovich P; Chenoweth DE; Schmidt R; Klinkmann H; Boxer LA; Jacob HS; Hammerschmidt DE
Kidney Int; 1983 Dec; 24(6):758-63. PubMed ID: 6609268
[TBL] [Abstract][Full Text] [Related]
2. Cellulose membranes--time for a change?
Henderson LW; Chenoweth DE
Contrib Nephrol; 1985; 44():112-26. PubMed ID: 3872769
[No Abstract] [Full Text] [Related]
3. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
Chenoweth DE; Cheung AK; Henderson LW
Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
[TBL] [Abstract][Full Text] [Related]
4. Complement C3 and C5 degradation products during hemodialysis treatment: study of an index of membrane bioincompatibility.
Freyria AM; Leitienne P; Veysseyre CN; Bringuier JP; Traeger J
Int J Artif Organs; 1988 Mar; 11(2):111-8. PubMed ID: 3259552
[TBL] [Abstract][Full Text] [Related]
5. Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers.
Hörl WH; Riegel W; Schollmeyer P; Rautenberg W; Neumann S
Clin Nephrol; 1986 Jun; 25(6):304-7. PubMed ID: 3015463
[TBL] [Abstract][Full Text] [Related]
6. Compartmental distribution of complement activation products in artificial kidneys.
Cheung AK; Chenoweth DE; Otsuka D; Henderson LW
Kidney Int; 1986 Jul; 30(1):74-80. PubMed ID: 3489123
[TBL] [Abstract][Full Text] [Related]
7. Effects of complement activation by hemodialysis membranes.
Cheung AK; Henderson LW
Am J Nephrol; 1986; 6(2):81-91. PubMed ID: 3518458
[No Abstract] [Full Text] [Related]
8. Anaphylatoxin formation during hemodialysis: comparison of new and re-used dialyzers.
Chenoweth DE; Cheung AK; Ward DM; Henderson LW
Kidney Int; 1983 Dec; 24(6):770-4. PubMed ID: 6609270
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
Germin Petrović D
Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
[TBL] [Abstract][Full Text] [Related]
10. A modification of cellulose that facilitates the control of complement activation.
Johnson RJ; Lelah MD; Sutliff TM; Boggs DR
Blood Purif; 1990; 8(6):318-28. PubMed ID: 2151203
[TBL] [Abstract][Full Text] [Related]
11. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels.
Varela MP; Kimmel PL; Phillips TM; Mishkin GJ; Lew SQ; Bosch JP
Blood Purif; 2001; 19(4):370-9. PubMed ID: 11574733
[TBL] [Abstract][Full Text] [Related]
12. Complement activation and hypersensitivity reactions to dialysis membranes.
Hakim RM; Breillatt J; Lazarus JM; Port FK
N Engl J Med; 1984 Oct; 311(14):878-82. PubMed ID: 6332276
[TBL] [Abstract][Full Text] [Related]
13. Biocompatibility of different hemodialysis and plasmapheresis membranes.
Jørstad S
Blood Purif; 1987; 5(2-3):123-37. PubMed ID: 3497645
[TBL] [Abstract][Full Text] [Related]
14. Complement activation during hemodialysis: clinical observations, proposed mechanisms, and theoretical implications.
Chenoweth DE
Artif Organs; 1984 Aug; 8(3):281-90. PubMed ID: 6332607
[TBL] [Abstract][Full Text] [Related]
15. Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia.
Wegmüller E; Montandon A; Nydegger U; Descoeudres C
Int J Artif Organs; 1986 Mar; 9(2):85-92. PubMed ID: 3699914
[TBL] [Abstract][Full Text] [Related]
16. Biocompatibility of artificial organs: an overview.
Henderson LW; Chenoweth D
Blood Purif; 1987; 5(2-3):100-11. PubMed ID: 3304344
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of main granulocyte components in patients dialyzed with polycarbonate and cuprophan membranes.
Hörl WH; Riegel W; Schollmeyer P
Nephron; 1987; 45(4):272-6. PubMed ID: 3035392
[TBL] [Abstract][Full Text] [Related]
18. Complement activation and neutropenia occurring during cardiopulmonary bypass.
Hammerschmidt DE; Stroncek DF; Bowers TK; Lammi-Keefe CJ; Kurth DM; Ozalins A; Nicoloff DM; Lillehei RC; Craddock PR; Jacob HS
J Thorac Cardiovasc Surg; 1981 Mar; 81(3):370-7. PubMed ID: 6970304
[TBL] [Abstract][Full Text] [Related]
19. Cellulose acetate hemodialysis membranes are better tolerated than Cuprophan. A difference in complement and neutrophil activation.
Ivanovich P; Chenoweth DE; Schmidt R; Klinkmann H; Boxer LA; Jacob HS; Hammerschmidt DE
Contrib Nephrol; 1984; 37():78-82. PubMed ID: 6713881
[No Abstract] [Full Text] [Related]
20. Dialysis leukopenia, hypoxemia, and anaphylatoxin formation: effect of membrane, bath, and citrate anticoagulation.
Wiegmann TB; MacDougall ML; Diederich DA
Am J Kidney Dis; 1988 May; 11(5):418-24. PubMed ID: 3259402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
